PNC Financial Services Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.4K | Buy |
|
|||||
|
2025
Q2 | $5.37K | Buy |
|
|||||
|
2025
Q1 | $1.8K | Buy |
|
|||||
|
2024
Q4 | $177 | Sell |
|
|||||
|
2024
Q3 | $8.33K | Sell |
|
|||||
|
2024
Q2 | $16K | Buy |
|
|||||
|
2024
Q1 | $16.5K | Sell |
|
|||||
|
2023
Q4 | $16.9K | Buy |
|
|||||
|
2023
Q3 | $10.8K | Sell |
|
|||||
|
2023
Q2 | $26.5K | Buy |
|
|||||
|
2023
Q1 | $17.4K | Hold |
|
|||||
|
2022
Q4 | $21.6K | Buy |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $3K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $18K | Hold |
|
|||||
|
2020
Q3 | $15K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $0 | Hold |
|
|||||
|
2019
Q2 | $0 | Hold |
|
|||||
|
2019
Q1 | $0 | Sell |
|
|||||
|
2018
Q4 | $0 | Hold |
|
|||||
|
2018
Q3 | $1K | Hold |
|
|||||
|
2018
Q2 | $1K | Hold |
|
|||||
|
2018
Q1 | $3K | Hold |
|
|||||
|
2017
Q4 | $3K | Sell |
|
|||||
|
2017
Q3 | $6K | Hold |
|
|||||
|
2017
Q2 | $5K | Hold |
|
|||||
|
2017
Q1 | $8K | Sell |
|
|||||
|
2016
Q4 | $11K | Sell |
|
|||||
|
2016
Q3 | $71K | Sell |
|
|||||
|
2016
Q2 | $79K | Sell |
|
|||||
|
2016
Q1 | $70K | Buy |
|
|||||
|
2015
Q4 | $211K | Buy |
|
|||||
|
2015
Q3 | $130K | Sell |
|
|||||
|
2015
Q2 | $331K | Buy |
|
|||||
|
2015
Q1 | $358K | Buy |
|
|||||
|
2014
Q4 | $233K | Buy |
|
|||||
|
2014
Q3 | $162K | Hold |
|
|||||
|
2014
Q2 | $204K | Buy |
|
|||||
|
2014
Q1 | $203K | Hold |
|
|||||
|
2013
Q4 | $278K | Hold |
|
|||||
|
2013
Q3 | $407K | Buy |
|
|||||
|
2013
Q2 | $55K | Buy |
|